Zdrowie i gospodarka · 02/01/2018

FDA Corrects Notice on Withdrawal of 54 Abbreviated New Drug Applications

The FDA is correcting a notice that incorrectly announced the withdrawal of approval for 54 abbreviated new drug applications, including one for Chlorthalidone Tablets USP, 25 milligrams, held by Watson Laboratories, Inc., a subsidiary of Teva Pharmaceuticals USA, Inc.